PHB2 and neoplasm: These findings indicate the precise pathophysiological contribution of BIG3 to PKA and PP1Cα for the inactivation of PHB2, which exerts a highly potent suppressive activity against multiple E2/ERα signalling pathways in E2-dependent breast carcinogenesis.